Search

Your search keyword '"El-Khouly, Fatima"' showing total 16 results
Start Over Author "El-Khouly, Fatima" Database Unpaywall
16 results on '"El-Khouly, Fatima"'

2. 2022-RA-1310-ESGO Cost-effectiveness of unselected multigene germline and somatic genetic testing for epithelial ovarian cancer

Author

Sun, Li, primary, Sobocan, Monika, additional, Rodriguez, Isabel V, additional, Wei, Xia, additional, Kalra, Ashwin, additional, Oxley, Samuel, additional, Sideris, Michail, additional, Morgan, Robert D, additional, Chandrasekaran, Dhivya, additional, Rust, Kelly, additional, Spiliopoulou, Pavlina, additional, Miller, Rowan E, additional, Crusz, Shanthini M, additional, Lockley, Michelle, additional, Singh, Naveena, additional, Faruqi, Asma, additional, Casey, Laura, additional, Brockbank, Elly, additional, Phadnis, Saurabh, additional, Mills-Baldock, Tina, additional, El-Khouly, Fatima, additional, Jenkins, Lucy A, additional, Wallace, Andrew, additional, Ahmed, Munaza, additional, Kumar, Ajith, additional, Swisher, Elizabeth M, additional, Gourley, Charlie, additional, Norquist, Barbara M, additional, Gareth Evans, D, additional, Legood, Rosa, additional, and Manchanda, Ranjit, additional

Published
2022
Full Text
View/download PDF

4. Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study

Author

Chandrasekaran, Dhivya, primary, Sobocan, Monika, additional, Blyuss, Oleg, additional, Miller, Rowan E., additional, Evans, Olivia, additional, Crusz, Shanthini M., additional, Mills-Baldock, Tina, additional, Sun, Li, additional, Hammond, Rory F. L., additional, Gaba, Faiza, additional, Jenkins, Lucy A., additional, Ahmed, Munaza, additional, Kumar, Ajith, additional, Jeyarajah, Arjun, additional, Lawrence, Alexandra C., additional, Brockbank, Elly, additional, Phadnis, Saurabh, additional, Quigley, Mary, additional, El Khouly, Fatima, additional, Wuntakal, Rekha, additional, Faruqi, Asma, additional, Trevisan, Giorgia, additional, Casey, Laura, additional, Burghel, George J., additional, Schlecht, Helene, additional, Bulman, Michael, additional, Smith, Philip, additional, Bowers, Naomi L., additional, Legood, Rosa, additional, Lockley, Michelle, additional, Wallace, Andrew, additional, Singh, Naveena, additional, Evans, D. Gareth, additional, and Manchanda, Ranjit, additional

Published
2021
Full Text
View/download PDF

5. ICON 9—an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy

Author

Elyashiv, Osnat, primary, Ledermann, Jonathan, additional, Parmar, Gita, additional, Farrelly, Laura, additional, Counsell, Nicholas, additional, Feeney, Amanda, additional, El-Khouly, Fatima, additional, Macdonald, Ian, additional, Neto, Andreia, additional, Arthur-Darkwa, Esther, additional, Burnett, Eva, additional, Jayson, Gordon C, additional, Mileshkin, Linda, additional, Gourley, Charlie, additional, and Nicum, Shibani, additional

Published
2020
Full Text
View/download PDF

6. Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours

Author

Evans, T. R. Jeffry, primary, Dean, Emma, additional, Molife, L. Rhoda, additional, Lopez, Juanita, additional, Ranson, Malcolm, additional, El-Khouly, Fatima, additional, Zubairi, Ishtiaq, additional, Savulsky, Claudio, additional, Reyderman, Larisa, additional, Jia, Yan, additional, Sweeting, Lorna, additional, Greystoke, Alastair, additional, Barriuso, Jorge, additional, and Kristeleit, Rebecca, additional

Published
2019
Full Text
View/download PDF

7. Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia

Author

Laskaratos, Faidon Marios, primary, Diamantopoulos, Leonidas, additional, Walker, Martin, additional, Walton, Henry, additional, Khalifa, Mohamed, additional, El-Khouly, Fatima, additional, Koffas, Apostolos, additional, Demetriou, George, additional, Caplin, Martyn, additional, Toumpanakis, Christos, additional, and Mandair, Dalvinder, additional

Published
2018
Full Text
View/download PDF

8. A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer

Author

Kristeleit, Rebecca, primary, Davidenko, Irina, additional, Shirinkin, Vadim, additional, El-Khouly, Fatima, additional, Bondarenko, Igor, additional, Goodheart, Michael J., additional, Gorbunova, Vera, additional, Penning, Carol A., additional, Shi, Jack G., additional, Liu, Xiangdong, additional, Newton, Robert C., additional, Zhao, Yufan, additional, Maleski, Janet, additional, Leopold, Lance, additional, and Schilder, Russell J., additional

Published
2017
Full Text
View/download PDF

9. Phase 1 multicenter, open-label study to establish the maximum tolerated dose (MTD) of two administration schedules of E7389 (eribulin) liposomal formulation in patients (pts) with solid tumors.

Author

Zubairi, Ishtiaq Husain, primary, Dean, Emma Jane, additional, Molife, L Rhoda, additional, Lopez, Juanita Suzanne, additional, Ranson, Malcolm, additional, El-Khouly, Fatima, additional, Savulsky, Claudio Isaac, additional, Reyderman, Larisa, additional, Jia, Yan, additional, Hutton, Emily, additional, Morrison, Rosemary, additional, Sweeting, Lorna, additional, Greystoke, Alastair, additional, Barriuso, Jorge, additional, Kristeleit, Rebecca Sophie, additional, and Evans, T.R. Jeffry, additional

Published
2016
Full Text
View/download PDF

11. Phase 1/2 study of oral rucaparib: Final phase 1 results.

Author

Kristeleit, Rebecca Sophie, primary, Burris, Howard A., additional, LoRusso, Patricia, additional, Patel, Manish R., additional, Asghar, Uzma Saddia, additional, El-Khouly, Fatima, additional, Calvert, Alan Hilary, additional, Infante, Jeffrey R., additional, Hilton, John Frederick, additional, Tolaney, Sara M., additional, Kittaneh, Muaiad, additional, Giordano, Heidi, additional, Borrow, Jennifer, additional, Jaw-Tsai, Sarah S., additional, and Shapiro, Geoffrey, additional

Published
2014
Full Text
View/download PDF

12. Phase I/IIa trial of the novel microtubule inhibitor BAL101553 in advanced solid tumors: Phase I completed.

Author

Molife, L Rhoda, primary, Imseeh, Georgios, additional, Capelan, Marta, additional, El-Khouly, Fatima, additional, Cresti, Nicola, additional, Smith, Alan David, additional, Averion, Dexter, additional, Md. Haris, Noor, additional, Stimpson, Sarah Jane, additional, Gumbleton, Todd, additional, Lane, Heidi A, additional, Bachmann, Felix, additional, Schmitt-Hoffmann, Anne, additional, Tzankov, Alexandar, additional, Hannah, Alison L., additional, Anderson, Stephanie, additional, Bette, Ullrich, additional, Calvert, Alan Hilary, additional, Plummer, Ruth, additional, and Kristeleit, Rebecca Sophie, additional

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results